Adenovirus-associated viral vector-based gene-replacement therapy for the treatment of arrhythmogenic cardiomyopathy: A risk–benefit perspective in an evolving field

Heart Rhythm 2026

View at publisher
Authors: Alessio Gasperetti, Hugh Calkins, Andreas S. Barth
DOI: 10.1016/j.hrthm.2026.03.1942
Cited by: 2
References: 57

Fields of Study & Subjects

Cardiovascular Effects of Exercise Viral Infections and Immunology Research Virus-based gene therapy research

Publication details

Journal / source
Heart Rhythm
Publisher
Elsevier BV
Volume
23
Issue
9
Pages
e2151–e2161
Publication date
31 March 2026
Language
EN